Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hemorrhage × Goserelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 74 Breast Neoplasms 45 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 3 Neoplasms 3 Recurrence 2 Osteoporosis 2 Neoplasm Metastasis 2 Leiomyoma 2 Breast Neoplasms, Male 2 Advanced Breast Cancer 2 Triple Negative Breast Neoplasms 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunction, Physiological 1 Radiation Injuries 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Hypertension 1 Hyperlipidemias 1 Hot Flashes 1 Hormone-sensitive Metastatic Breast Cancer 1 Hormone Sensitive Prostate Cancer 1 Hodgkin Disease 1 Hemorrhage 1

Interventions

Tranexamic Acid 11 Sodium Chloride 4 Saline Solution 3 Misoprostol 3 carbetocin 2 Tourniquets 2 Endoscopic Mucosal Resection 2 Vitamin B 6 1 Vasopressins 1 Uterine Artery Embolization 1 Ultrasonography 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Sutures 1 Surveys and Questionnaires 1 Surgicel 1 Standard of Care 1 Solutions 1 Sensitivity Training Groups 1 Rivaroxaban 1 Ringer's Lactate 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Palliative Care 1 Oxytocin 1 Neuromuscular Blockade 1 N(4)-oleylcytosine arabinoside 1 Methylergonovine 1 Mannitol 1 Injections, Intravenous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01581944 2012-04-20

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Mt. Hope Maternity Hospital

Phase 3 Completed

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡